ACAD
ACADIA Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +4.5% ·
Aktienfluss +4.0% ·
neue Nettopositionen 0.0%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 121 | +9 | 90.97M | $2.30B | +11 | −2 |
| Q1 2026 | 115 | -3 | 85.30M | $1.90B | +4 | −8 |
| Q4 2025 | 119 | 0 | 93.96M | $2.51B | +1 | — |
| Q3 2025 | 23 | +1 | 66.53M | $1.42B | +1 | −1 |
| Q2 2025 | 20 | +2 | 61.51M | $1.33B | +2 | — |
| Q1 2025 | 15 | 0 | 22.54M | $374.41M | — | — |
| Q4 2024 | 15 | +1 | 20.32M | $372.93M | +1 | — |
| Q3 2024 | 13 | -1 | 13.63M | $209.57M | — | −1 |
| Q2 2024 | 14 | — | 19.35M | $314.37M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 20.27M | -1.9% | $432.53M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (passiv) | 15.18M | -0.6% | $323.93M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passiv) | 7.26M | +17.4% | $154.83M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 3.13M | +3.6% | $66.86M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Adage Capital Partners ✦ | 2.48M | +311.4% | $53.01M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 2.36M | +19.8% | $50.34M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 2.10M | — | $44.87M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 1.65M | +390.1% | $35.19M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 1.56M | -20.5% | $33.32M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Point72 Asset Management ✦ | 1.49M | -53.1% | $31.72M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.48M | +2052.1% | $31.65M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 1.45M | -6.3% | $30.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 1.19M | — | $25.36M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 14 | T. Rowe Price ✦ | 1.10M | +18.5% | $23.49M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Two Sigma Investments ✦ | 665.89K | +37.8% | $14.21M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 665.81K | +293.1% | $14.21M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 17 | JPMorgan Chase ✦ | 651.84K | — | $13.91M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 18 | Fisher Asset Management ✦ | 638.49K | +105.8% | $13.63M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 620.83K | +112.8% | $13.25M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 20 | Citadel Advisors ✦ | 323.52K | -89.3% | $6.90M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 21 | Bridgewater Associates ✦ | 163.25K | Neu | $3.48M | 0.0% | New | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 55.34K | +11.6% | $1.18M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 23 | Gotham Asset Management ✦ | 43.17K | +145.2% | $921,184 | 0.0% | ▲ Add | 6 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Bridgewater Associates | $3.48M | 0.0% |
Ausgestiegen
| Norges Bank | $31.68M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 337 Inhaber, 164.47M Anteile, $3.62B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.